Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute www.indianactsi.org Mycobacterium.

Slides:

Advertisements

Similar presentations

Agenda Background Current testings Xpert MTB/RIF product PAGE | 1.

Advertisements

New approaches in TB diagnosis and treatment Prof. M.A. Tageldin.

Lab on a Chip Or: The Incredible Shrinking Science Experiment! Or: APOIBE! Dr. Eric Lagally Credits: Mathies Lab, UC-Berkeley Quake.

Biotechnology and Medicine Prof. S.K.Panda Department of Pathology All India Institute of Medical Sciences.

Prize for TB low-cost point of care rapid diagnostic test Pierre Chirac Médecins Sans Frontières, Paris, France Campaign for Access to Essential Medicines.

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Jessica E.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.

Advocacy for TB POC Diagnostic Javid Syed TB/HIV 15th Core Group Meeting Nov 3-4, Geneva.

Experimental pathology refers to the observation of the effects of manipulations on animal models or cell cultures regarding researches on human diseases.

Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.

Biotechnology Unit 3.04.

Tuberculosis quick facts Illustrated through drawings from children across the Region Philippines.

Protein arrays LEAPS technology An array of 110 different antibodies incubated with various levels of the fluorescently labelled cognate antigens in a.

Einstein-Montefiore CFAR Virology Core Director: Dr. Ganjam V. Kalpana, Ph.D.

Antigen antibody reactions

Innovation in TB control: what’s in it for the field? Peter C.F.M. Gondrie, MD, MPH Executive Director

Catherine Klapperich, Ph.D.

Pulmonary tuberculosis

 Study of the immune system  How the body protects itself against foreign, potentially disease-causing microorganisms  Three main functions:  To recognize.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH A simple, flexible tool for inexpensively building secure data capture systems Andy.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana CTSI 101 Indiana Clinical and Translational Sciences Institute Monday, October.

Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.

HIV and TB Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Program in Global Health, Division of Infectious Diseases David Geffen.

Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Daniel F. Evans,

IndianaCTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH The Indiana CTSI HUB Bill Barnett Director, Information Infrastructures, Indiana CTSI

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

Adult Medical-Surgical Nursing Respiratory Module: Tuberculosis.

1 FIND and Operational Research in HIV-Associated Tuberculosis Rick O’Brien Foundation for Innovative New Diagnostics, Geneva.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH

Introduction to Tuberculosis Genotyping National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination.

Tuberculosis The evolution of a bacterium. 2 World Health Organization (WH.O. declared TB a global health emergency in cases per 100,

HIV/ AIDS Right now, 1 out of every 300 people in the United States has HIV, the virus that causes AIDS.

Revision of new diagnostics for TB

The contents of pathology The contents of pathology   Aetiology (the causes )   Pathogenesis (mechanisms)   pathologic changes: structural & functional.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana CTSI 2014 Purdue Retreat Engagement with IU Health Arnett Marietta L. Harrison,

Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.

Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.

The Acid Fast Cell Wall Dr. Jennifer Coetzee.

Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.

Detection, Prophylaxis and Treatment of Bacterial Infection.

ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Scott C. Denne, MD Associate Director, Indiana CTSI April 25, 2011 Plenary Session.

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Health Information.

CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.

Using implementation science to improve child household contact screening for tuberculosis in Eldoret, Kenya: Overview and lessons learned Daria Szkwarko,

Unit 1.1 Review MI.

INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS Identification of Mycobacterium tuberculosis complex in clinical specimens of HIV-infected patients at Instituto.

TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.

Molecular Diagnostics Market – Global Industry Analysis Report, Share, Size, Growth, Price.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Molecular Diagnostics Market share to surpass USD 4 billion by 2023.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.

Tuberculosis in children

New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.

HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Bioreactor Market to surpass.

LAM assay: overview and practical guidance on its adoption and use

P RESENTATION T OPIC : I NTRODUCTION TO D IAGNOSTIC B ACTERIOLOGY Subject: Systematic Diagnostic Bacteriology Muhammad Abbas BS MLT F.sc MLT Rehman College.

Presentation 10 Analysing results and defining cases

Evidence for use of urinary LAM

Further explorations of surveillance data: case detection (all cases vs. bacteriologically confirmed, All strategies) Good afternoon. I will give a brief.

Communicable and non communicable diseases

Figure 1. Evaluation the sensitivity and specificity value of urine LAM and sputum AFB Procedure using GeneXpert as the Reference (Gold Standard) From:

Deciphering TB Lab Reports

H. M. El Sahly, L.D. Teeter, J.M. Musser, E.A. Graviss

Nanotechnology to improve the diagnosis of tuberculosis in children

TB Screening and Differentiated Service Delivery: State of the Art

Presentation transcript:

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Mycobacterium tuberculosis One third of the world population is currently infected. Over 8 million new cases of TB in % of those infected become sick or infectious at some time in their lives. An estimated 1.6 million TB deaths occurred in Drug-resistance is on the rise No effective vaccine against pulmonary TB

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Lines of Investigation– Schorey laboratory Molecular and cellular basis of TB pathogenesis. Exosomes as TB vaccine candidates Diagnostic tools for TB. Supported by: National Institutes of Health - R01 AI R01 AI Gates Exploration Grant

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute What is available: Acid-fast smear test using sputum Culturing approaches using sputum as the source of bacilli Detection from patient blood antibodies or T cells specific for mycobacterial components Detection of M.tb DNA or RNA in patient bodily fluids or sputum Detection of other mycobacterial components in patient bodily fluids Diagnostic needs: High specificity and sensitivity as well as a test which is rapid, requires minimum manipulation, easy to use and is of minimal cost.

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute TB Diagnostic Development Through Research and Industrial Collaboration Indiana Clinical and Translational Sciences Institute (ICTSI) University of Notre Dame’s College of Engineering and College of Science Advanced Diagnostics and Therapeutics and the Eck Institute for Global Health Academic Model for the Prevention and Treatment of HIV/AIDS (AMPATH) and the IU School of Medicine Companion Diagnostics Inc. Sony DADC (Polymer Devices Branch of SONY)

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Isolation of M. tuberculosis Lipoarabinomannan (LAM) from urine of TB patients using an antibody-based microfluidic detection platform TB Detection Project Couple LAM antibodies to chip/sensor substrate using micro-stamping techniques. Converting current glass microfluidic platform to hard plastic, including synthesis of on-chip membranes Develop and assemble hand-held chip reader and design large-scale hard polymer chip production methods. Test chip prototypes first using urine “spiked” with LAM, then urine samples from TB patients (Kenya) and control samples.

Indiana CTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Indiana C linical and T ranslational S ciences I nstitute Detection Platform An open-flow impedance-sensing platform for LAM binding to a antibody functionalized carbon nanotube surface in the presence of a high-frequency AC electric field.